WallStreetZenWallStreetZen

NASDAQ: VAXX
Vaxxinity Inc Stock

$1.37-0.03 (-2.14%)
Updated Sep 29, 2023
VAXX Price
$1.37
Fair Value Price
N/A
Market Cap
$173.64M
52 Week Low
$1.24
52 Week High
$4.47
P/E
-2.36x
P/B
4.96x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$72.11M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.04
Operating Cash Flow
-$58M
Beta
0.95
Next Earnings
Nov 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

VAXX Overview

Vaxxinity Incorporated develops products in the fields of neurology and coronaviruses in the U.S. Its pipeline includes UB-311, in Phase 2 clinical trials to treat Alzheimer's disease, UB-312 to treat Parkinson's disease, and UB-612, in Phase 3 clinical trials to neutralize the SARS-CoV-2 virus. The company was founded in 2014 and is headquartered in Dallas, TX.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VAXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VAXX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VAXX is good value based on its book value relative to its share price (4.96x), compared to the US Biotechnology industry average (5.09x)
P/B vs Industry Valuation
VAXX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more VAXX due diligence checks available for Premium users.

Be the first to know about important VAXX news, forecast changes, insider trades & much more!

VAXX News

Valuation

VAXX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.36x
Industry
13.67x
Market
12.37x

VAXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.96x
Industry
5.09x
VAXX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VAXX's financial health

Profit margin

Revenue
$0.0
Net Income
-$14.0M
Profit Margin
0%
VAXX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$71.4M
Liabilities
$36.4M
Debt to equity
1.04
VAXX's short-term assets ($59.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VAXX's short-term assets ($59.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VAXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$12.2M
Investing
$26.6M
Financing
$126.0k
VAXX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VAXX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VAXX$173.64M-2.14%-2.36x4.96x
TNYA$173.06M-0.97%-1.16x0.91x
STOK$174.37M+4.23%-1.56x0.92x
IFRX$175.47M+1.02%-3.62x1.28x
ORTX$175.65M-0.77%-1.25x1.61x

Vaxxinity Stock FAQ

What is Vaxxinity's quote symbol?

(NASDAQ: VAXX) Vaxxinity trades on the NASDAQ under the ticker symbol VAXX. Vaxxinity stock quotes can also be displayed as NASDAQ: VAXX.

If you're new to stock investing, here's how to buy Vaxxinity stock.

What is the 52 week high and low for Vaxxinity (NASDAQ: VAXX)?

(NASDAQ: VAXX) Vaxxinity's 52-week high was $4.47, and its 52-week low was $1.24. It is currently -69.35% from its 52-week high and 10.48% from its 52-week low.

How much is Vaxxinity stock worth today?

(NASDAQ: VAXX) Vaxxinity currently has 126,745,044 outstanding shares. With Vaxxinity stock trading at $1.37 per share, the total value of Vaxxinity stock (market capitalization) is $173.64M.

Vaxxinity stock was originally listed at a price of $16.55 in Nov 11, 2021. If you had invested in Vaxxinity stock at $16.55, your return over the last 1 years would have been -91.72%, for an annualized return of -91.72% (not including any dividends or dividend reinvestments).

How much is Vaxxinity's stock price per share?

(NASDAQ: VAXX) Vaxxinity stock price per share is $1.37 today (as of Sep 29, 2023).

What is Vaxxinity's Market Cap?

(NASDAQ: VAXX) Vaxxinity's market cap is $173.64M, as of Oct 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vaxxinity's market cap is calculated by multiplying VAXX's current stock price of $1.37 by VAXX's total outstanding shares of 126,745,044.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.